510(k) K262168

QIAstat-Dx BCID GN Plus AMR Panel by QIAGEN GmbH — Product Code PEN

K262168 is an FDA 510(k) premarket notification submitted by QIAGEN GmbH for the device "QIAstat-Dx BCID GN Plus AMR Panel". The FDA issued a decision of Substantially Equivalent on Sep 24, 2026. The device falls under product code PEN (Gram-Negative Bacteria And Associated Resistance Markers), a Class II device regulated under 21 CFR 866.3365. QIAGEN GmbH has 17 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 24, 2026
Date Received
Jun 26, 2026
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Gram-Negative Bacteria And Associated Resistance Markers
Device Class
Class II
Regulation Number
866.3365
Review Panel
MI
Submission Type
510(k)

A qualitative multiplexed in vitro diagnostic device to detect and identify gram-negative bacteria and resistance markers in positive blood cultures.

Need the full FDA record for QIAGEN GmbH? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K262168. Report a data issue: hello@regdatalab.com.